The GvHD Hub uses cookies on this website. They help us give you the best online experience. By continuing to use our website without changing your cookie settings, you agree to our use of cookies in accordance with our updated Cookie Policy

What factors impact response to mesenchymal stromal cells in patients with acute GvHD?

During the 25th Congress of the European Hematology Association (EHA), the GvHD Hub spoke to Antonio Galleu, King's College London, London, UK. We asked: What factors impact response to mesenchymal stromal cells in patients with acute GvHD?

Influencing factors include prognostic markers identified prior to infusion, characteristic molecular changes observed during or following mesenchymal stromal cell treatment, or characteristics of the treatment itself. Here, Antonio Galleu discusses the key determinants of patient outcome to mesenchymal stromal cell infusion.

What factors impact response to mesenchymal stromal cells in patients with acute GvHD?

Share: